Beyond formulation: contributions of nanotechnology for translation of anticancer natural products into new drugs (2022)
- Authors:
- USP affiliated authors: LOPES, LUCIANA BIAGINI - ICB ; LOTUFO, LETICIA VERAS COSTA - ICB ; MIGUEL, RODRIGO DOS ANJOS - ICB ; HIRATA, AMANDA SOARES - ICB
- Unidade: ICB
- DOI: 10.3390/pharmaceutics14081722
- Subjects: FARMACOLOGIA; QUIMIOTERÁPICOS; PRODUTOS NATURAIS; NANOTECNOLOGIA; ANTIBIÓTICOS; ANTINEOPLÁSICOS; FÁRMACOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Pharmaceutics
- ISSN: 1999-4923
- Volume/Número/Paginação/Ano: v. 14, n. 8, art. 1722, p. 1-28, 2022
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
MIGUEL, Rodrigo dos Anjos et al. Beyond formulation: contributions of nanotechnology for translation of anticancer natural products into new drugs. Pharmaceutics, v. 14, n. 8, p. 1-28, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14081722. Acesso em: 31 mar. 2026. -
APA
Miguel, R. dos A., Hirata, A. S., Jimenez, P. C., Lopes, L. B., & Costa-Lotufo, L. V. (2022). Beyond formulation: contributions of nanotechnology for translation of anticancer natural products into new drugs. Pharmaceutics, 14( 8), 1-28. doi:10.3390/pharmaceutics14081722 -
NLM
Miguel R dos A, Hirata AS, Jimenez PC, Lopes LB, Costa-Lotufo LV. Beyond formulation: contributions of nanotechnology for translation of anticancer natural products into new drugs [Internet]. Pharmaceutics. 2022 ; 14( 8): 1-28.[citado 2026 mar. 31 ] Available from: https://doi.org/10.3390/pharmaceutics14081722 -
Vancouver
Miguel R dos A, Hirata AS, Jimenez PC, Lopes LB, Costa-Lotufo LV. Beyond formulation: contributions of nanotechnology for translation of anticancer natural products into new drugs [Internet]. Pharmaceutics. 2022 ; 14( 8): 1-28.[citado 2026 mar. 31 ] Available from: https://doi.org/10.3390/pharmaceutics14081722 - Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline
- Preclinical development of seriniquinones as selective dermcidin modulators for the treatment of melanoma
- Topical delivery of seriniquinone for treatment of skin cancer and fungal infections is enabled by a liquid crystalline lamellar phase
- Multifunctional nanoemulsions promote cutaneous co-localization of chemotherapeutic agents and improve efficacy in 3D models of skin cancer
- Co-encapsulation of paclitaxel and C6 ceramide in tributyrin-containing nanocarriers improve co-localization in the skin and potentiate cytotoxic effects in 2D and 3D models
- Thermosensitive polymeric nanoparticles for drug Co-encapsulation and breast cancer treatment
- Caracterização do mecanismo de ação da seriniquinona e derivados sintéticos em modelos celulares de melanoma
- Seriniquinones as therapeutic leads for treatment of BRAF and NRAS mutant melanomas
- Seriniquinone, metabolite from a marine bacterium, and its synthetic derivative for melanoma and resistant melanoma cells treatment
- Bismuth(III) triflate: an economical and environmentally friendly catalyst for the Nazarov reaction
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
Beyond Formulation. Contr... | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
